25 research outputs found
Testing and treatment parameters used including estimated ranges around each parameter.
a<p>CI  =  95% Confidence Interval.</p>b<p>IQR  =  Interquartile range.</p>c<p>RR  =  Relative Risk.</p><p>Testing and treatment parameters used including estimated ranges around each parameter.</p
<i>H. pylori</i> management strategies included in the analysis.
<p><i>H. pylori</i> management strategies included in the analysis.</p
Net cost per cancer prevented (US dollars) for each strategy at varying prevalence rates of <i>H. pylori</i>.
<p>Net cost per cancer prevented (US dollars) for each strategy at varying prevalence rates of <i>H. pylori</i>.</p
Net cost per number of cancers prevented for different strategies for management of <i>H. pylori</i> in a population with a 50% prevalence of <i>H. pylori infection</i> (ICER).
<p>Red line indicates lowest net cost per cancer prevented.</p
Net cost per number of cancers prevented for different strategies for screening and treatment of <i>H. pylori</i> in a population with a 75% prevalence of <i>H. pylori infection</i> shown as an Incremental Cost Effectiveness Ratio (ICER).
<p>Red line indicates lowest net cost per cancer prevented.</p
Total cost (US dollars) and number of gastric cancers and ulcers prevented for each strategy for every 1000 people managed.
<p>Total cost (US dollars) and number of gastric cancers and ulcers prevented for each strategy for every 1000 people managed.</p
Net cost per number of cancers prevented for different strategies for screening and treatment of <i>H. pylori</i> in a population with a 25% prevalence of <i>H. pylori infection</i> (ICER).
<p>Red line indicates lowest net cost per cancer prevented.</p
Costs of testing and treatment for <i>H.pylori,</i> and costs of adverse outcomes associated with <i>H.pylori</i> in US dollars.
<p>Costs of testing and treatment for <i>H.pylori,</i> and costs of adverse outcomes associated with <i>H.pylori</i> in US dollars.</p
Sensitivity analysis for the most cost effective strategy (stool antigen with retesting).
<p>Horizontal bars represent the estimated net effect on cost per cancer prevented in US Dollars with a 1% increase in the listed parameters.</p